Literature DB >> 7110989

[Influence of cimetidine on bacterial growth in gastric fluid (author's transl)].

A Forster, T Niethamer, P Suter, J J Pitteloud, F Intante, G Ducel, D Morel.   

Abstract

Samples of gastric fluid were tested for pH and number of bacteria in 20 patients who received cimetidine 400 mg prior to selective gastric surgery. The results were compared with those obtained in a group of surgical patients who did not receive the drug. The cimetidine-treated patients had alkaline gastric fluid with pronounced bacterial growth (4.7 +/- 0.6 x 10(4) micro-organisms/ml), whereas 18/20 untreated patients has a sterile gastric fluid. Similar results were observed in 14 intensive care patients treated for 24 hours with cimetidine. The effect proved reversible: 12 hours after treatment was discontinued bacterial growth could only be demonstrated in 3/14 patients. Thus, short-term cimetidine treatment results in a rise of gastric pH with marked bacterial proliferation. This may have serious consequences in cimetidine-treated patients about to undergo gastric surgery or likely to develop aspiration pneumonia.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7110989

Source DB:  PubMed          Journal:  Nouv Presse Med        ISSN: 0301-1518


  4 in total

1.  More on gastric colonization, H2 antagonists or antacids.

Authors:  M Tryba
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

Review 2.  H2-receptor antagonists and gastric cancer.

Authors:  J Penston; K G Wormsley
Journal:  Med Toxicol       Date:  1986 May-Jun

3.  Duodenal bacterial overgrowth during treatment in outpatients with omeprazole.

Authors:  M Fried; H Siegrist; R Frei; F Froehlich; P Duroux; J Thorens; A Blum; J Bille; J J Gonvers; K Gyr
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

4.  Effect of histamine-2-receptor antagonists versus sucralfate on stress ulcer prophylaxis in mechanically ventilated patients: a meta-analysis of 10 randomized controlled trials.

Authors:  Jiahao Huang; Yunfei Cao; Cun Liao; Liucheng Wu; Feng Gao
Journal:  Crit Care       Date:  2010-10-29       Impact factor: 9.097

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.